Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
2.66
Dollar change
-0.12
Percentage change
-4.32
%
Index- P/E- EPS (ttm)-5.12 Insider Own8.50% Shs Outstand25.57M Perf Week4.31%
Market Cap68.10M Forward P/E- EPS next Y-1.49 Insider Trans0.00% Shs Float23.42M Perf Month-6.67%
Income-81.41M PEG- EPS next Q-0.58 Inst Own23.99% Short Float4.81% Perf Quarter-39.95%
Sales0.00M P/S- EPS this Y43.40% Inst Trans-5.07% Short Ratio4.60 Perf Half Y88.65%
Book/sh2.35 P/B1.13 EPS next Y33.85% ROA-113.72% Short Interest1.13M Perf Year-14.19%
Cash/sh2.76 P/C0.96 EPS next 5Y-2.49% ROE-136.82% 52W Range1.24 - 10.20 Perf YTD-35.83%
Dividend Est.- P/FCF- EPS past 5Y28.36% ROI-135.37% 52W High-73.92% Beta0.58
Dividend TTM- Quick Ratio5.64 Sales past 5Y-20.00% Gross Margin- 52W Low115.38% ATR (14)0.26
Dividend Ex-Date- Current Ratio5.64 EPS Y/Y TTM-6.12% Oper. Margin0.00% RSI (14)51.57 Volatility9.49% 10.02%
Employees54 Debt/Eq0.00 Sales Y/Y TTM-100.00% Profit Margin- Recom1.40 Target Price11.80
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q56.78% Payout- Rel Volume0.79 Prev Close2.78
Sales Surprise- EPS Surprise15.44% Sales Q/Q- EarningsMar 18 BMO Avg Volume244.95K Price2.66
SMA207.58% SMA50-6.09% SMA2000.40% Trades Volume192,372 Change-4.32%
Date Action Analyst Rating Change Price Target Change
Oct-04-21Initiated Mizuho Buy $6
Jun-04-21Resumed Robert W. Baird Outperform $5
Jun-29-20Initiated Piper Sandler Overweight $6
Feb-11-20Initiated Robert W. Baird Outperform $6
Nov-15-19Downgrade Raymond James Outperform → Mkt Perform
Sep-13-19Resumed Raymond James Outperform
Mar-07-17Initiated Ladenburg Thalmann Buy $18
Mar-20-24 09:35AM
Mar-18-24 07:00AM
Jan-16-24 05:05PM
Jan-03-24 07:00AM
Jan-02-24 07:00AM
04:05PM Loading…
Dec-11-23 04:05PM
Nov-21-23 07:00AM
Nov-13-23 07:00AM
Oct-24-23 12:30PM
Oct-03-23 09:55AM
Sep-05-23 07:00AM
Aug-14-23 07:00AM
Aug-13-23 10:44AM
Jul-12-23 07:00AM
Jun-20-23 12:30PM
07:11AM Loading…
Jun-04-23 07:11AM
May-25-23 05:10PM
May-15-23 07:00AM
Apr-26-23 04:05PM
Apr-12-23 07:00AM
Apr-04-23 11:10AM
Mar-24-23 07:00AM
Mar-17-23 12:26PM
Mar-16-23 04:05PM
Jan-17-23 05:13PM
09:24AM
08:00AM
Jan-11-23 07:00AM
Nov-21-22 07:00AM
Nov-16-22 05:20AM
07:00AM Loading…
Nov-14-22 07:00AM
Nov-07-22 08:05AM
Oct-26-22 08:19AM
Oct-17-22 07:00AM
Oct-12-22 07:00AM
Oct-05-22 08:05AM
Sep-27-22 08:15AM
Sep-07-22 07:00AM
Sep-06-22 07:00AM
Sep-04-22 06:05PM
Aug-12-22 07:00AM
07:00AM
Jul-21-22 07:47AM
Jul-14-22 11:37AM
11:34AM
Jul-12-22 11:20AM
11:13AM
07:00AM
Jul-11-22 11:58AM
06:19AM
Jul-08-22 11:48AM
11:14AM
Jul-07-22 11:22AM
Jul-04-22 11:49AM
Jun-29-22 12:44PM
12:34PM
Jun-28-22 11:52AM
Jun-27-22 07:00AM
Jun-17-22 11:16AM
Jun-13-22 12:01PM
Jun-10-22 10:51AM
Jun-09-22 10:48AM
Jun-08-22 10:14AM
Jun-07-22 11:30AM
11:23AM
Jun-06-22 10:13AM
09:48AM
Jun-03-22 10:51AM
10:49AM
Jun-02-22 12:09PM
11:24AM
May-31-22 11:26AM
May-26-22 05:00PM
11:18AM
May-25-22 12:07PM
12:05PM
May-24-22 10:58AM
May-23-22 11:46AM
11:33AM
May-19-22 06:15AM
May-13-22 07:00AM
Apr-09-22 08:57AM
Mar-11-22 07:00AM
Mar-02-22 07:00AM
Mar-01-22 09:45AM
Feb-25-22 08:25AM
Feb-15-22 10:14AM
Feb-08-22 07:56AM
Feb-03-22 05:38PM
Jan-31-22 07:00AM
Jan-24-22 07:00AM
Jan-21-22 05:38PM
Jan-19-22 02:07PM
09:02AM
06:18AM
06:07AM
Jan-18-22 05:00PM
Jan-16-22 10:30AM
Jan-12-22 01:58PM
Jan-05-22 07:00AM
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.